Gene ontology annotations for S100A8 |
|
Experiment description of studies that identified S100A8 in exosomes |
1 |
Experiment ID |
76 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|GAPDH|HSP90|CD81|CD9|CD63|LAMP1|MHCI
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20224111
|
Organism |
Homo sapiens |
Experiment description |
Proteomics analysis of bladder cancer exosomes. |
Authors |
"Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A." |
Journal name |
MCP
|
Publication year |
2010 |
Sample |
Bladder cancer cells |
Sample name |
HT1376 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.10-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF/TOF] Western blotting FACS |
|
|
2 |
Experiment ID |
1221 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|GAPDH
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
31054213
|
Organism |
Homo sapiens |
Experiment description |
Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma |
Authors |
"Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C." |
Journal name |
Proteomics
|
Publication year |
2019 |
Sample |
Cholangiocarcinoma cells |
Sample name |
KKU-M213 |
Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation Sucrose density gradient centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
3 |
Experiment ID |
1222 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|GAPDH
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
31054213
|
Organism |
Homo sapiens |
Experiment description |
Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma |
Authors |
"Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C." |
Journal name |
Proteomics
|
Publication year |
2019 |
Sample |
Cholangiocarcinoma cells |
Sample name |
KKU-M213D5 |
Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation Sucrose density gradient centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
4 |
Experiment ID |
494 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD151|CD63|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Osteoarthritic cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
5 |
Experiment ID |
496 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Healthy cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
6 |
Experiment ID |
497 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
7 |
Experiment ID |
498 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
8 |
Experiment ID |
363 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
9 |
Experiment ID |
364 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
10 |
Experiment ID |
365 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
11 |
Experiment ID |
266 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|Alix
|
Enriched markers |
✔
CANX|HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25265333
|
Organism |
Homo sapiens |
Experiment description |
Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS |
Authors |
"Zhao X, Wu Y, Duan J, Ma Y, Shen Z, Wei L, Cui X, Zhang J, Xie Y, Liu J" |
Journal name |
J Proteome Res
|
Publication year |
2014 |
Sample |
Liver cancer cells |
Sample name |
Huh-7 - Wild type |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
12 |
Experiment ID |
268 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|Alix
|
Enriched markers |
✔
CANX|HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25265333
|
Organism |
Homo sapiens |
Experiment description |
Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS |
Authors |
"Zhao X, Wu Y, Duan J, Ma Y, Shen Z, Wei L, Cui X, Zhang J, Xie Y, Liu J" |
Journal name |
J Proteome Res
|
Publication year |
2014 |
Sample |
Liver cancer cells |
Sample name |
Huh-7 - Transfected with HBx-null HBV replicon plasmids |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
13 |
Experiment ID |
126 |
MISEV standards |
✘
|
Biophysical techniques |
✔
GAPDH
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Antibody array
|
PubMed ID |
Unpublished / Not applicable
|
Organism |
Homo sapiens |
Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
Journal name |
Mesenchymal Stem Cell Therapy
|
Publication year |
2011 |
Sample |
Mesenchymal stem cells |
Sample name |
huES9.E1 |
Isolation/purification methods |
HPLC |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Antobody array Mass spectrometry |
|
|
14 |
Experiment ID |
231 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD63|CD9
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
15 |
Experiment ID |
232 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
16 |
Experiment ID |
233 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
17 |
Experiment ID |
66 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19199708
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
Journal name |
JPR
|
Publication year |
2009 |
Sample |
Saliva |
Sample name |
Saliva |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
18 |
Experiment ID |
191 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD81|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20124223
|
Organism |
Homo sapiens |
Experiment description |
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. |
Authors |
"Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2010 |
Sample |
Squamous carcinoma cells |
Sample name |
Squamous carcinoma cell (A431) |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
19 |
Experiment ID |
63 |
MISEV standards |
✘
|
Biophysical techniques |
✔
AQP2
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19056867
|
Organism |
Homo sapiens |
Experiment description |
Large-scale proteomics and phosphoproteomics of urinary exosomes. |
Authors |
"Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA" |
Journal name |
JASN
|
Publication year |
2009 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
20 |
Experiment ID |
196 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
22418980
|
Organism |
Homo sapiens |
Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
Journal name |
Kidney Int
|
Publication year |
2012 |
Sample |
Urine |
Sample name |
Urine - Normal high density |
Isolation/purification methods |
Differential centrifugation Sucrose cushion |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
21 |
Experiment ID |
197 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
22418980
|
Organism |
Homo sapiens |
Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
Journal name |
Kidney Int
|
Publication year |
2012 |
Sample |
Urine |
Sample name |
Urine - Normal low density |
Isolation/purification methods |
Differential centrifugation Sucrose cushion |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for S100A8 |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
RALY |
22913 |
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
EDEM1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
3 |
RPL26L1 |
51121 |
Affinity Capture-MS |
|
Homo sapiens |
|
4 |
SERPINB4 |
6318 |
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
TCEB1 |
6921 |
Affinity Capture-MS |
|
Homo sapiens |
|
6 |
PHF21B |
|
Affinity Capture-MS |
|
Homo sapiens |
|
7 |
PAXIP1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
POT1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
ANXA2 |
302 |
Affinity Capture-MS |
|
Homo sapiens |
|
10 |
MARCH2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
11 |
GDF9 |
2661 |
Two-hybrid |
|
Homo sapiens |
|
12 |
MPO |
4353 |
Co-fractionation |
|
Homo sapiens |
|
13 |
CSTA |
1475 |
Affinity Capture-MS |
|
Homo sapiens |
|
14 |
VHL |
|
Affinity Capture-MS |
|
Homo sapiens |
|
15 |
ST7 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
16 |
AZGP1 |
563 |
Affinity Capture-MS |
|
Homo sapiens |
|
17 |
FNDC5 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
18 |
KIAA1429 |
25962 |
Affinity Capture-MS |
|
Homo sapiens |
|
19 |
B3GNT2 |
10678 |
Affinity Capture-MS |
|
Homo sapiens |
|
20 |
RNF5 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
21 |
CEMIP |
57214 |
Affinity Capture-MS |
|
Homo sapiens |
|
22 |
MCM2 |
4171 |
Affinity Capture-MS |
|
Homo sapiens |
|
23 |
COPS5 |
10987 |
Affinity Capture-MS |
|
Homo sapiens |
|
24 |
FBXW7 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
25 |
NUDT3 |
11165 |
Affinity Capture-MS |
|
Homo sapiens |
|
26 |
ELF1 |
1997 |
Proximity Label-MS |
|
Homo sapiens |
|
27 |
ARHGEF10 |
9639 |
Affinity Capture-MS |
|
Homo sapiens |
|
28 |
USF2 |
7392 |
Affinity Capture-MS |
|
Homo sapiens |
|
29 |
CHGB |
1114 |
Two-hybrid |
|
Homo sapiens |
|
30 |
SLX4 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
SHC1 |
6464 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
32 |
C14orf1 |
11161 |
Two-hybrid |
|
Homo sapiens |
|
33 |
C18orf21 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
GSK3B |
2932 |
Affinity Capture-MS |
|
Homo sapiens |
|
35 |
PPM1B |
5495 |
Affinity Capture-MS |
|
Homo sapiens |
|
36 |
NF2 |
4771 |
Affinity Capture-MS |
|
Homo sapiens |
|
37 |
DLD |
1738 |
Affinity Capture-MS |
|
Homo sapiens |
|
38 |
OCRL |
4952 |
Affinity Capture-MS |
|
Homo sapiens |
|
39 |
CDKN1A |
|
Two-hybrid |
|
Homo sapiens |
|
40 |
PARK2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
41 |
TUBA1A |
7846 |
Reconstituted Complex |
|
Homo sapiens |
|
42 |
WRAP73 |
49856 |
Affinity Capture-MS |
|
Homo sapiens |
|
43 |
LRIF1 |
|
Two-hybrid |
|
Homo sapiens |
|
44 |
Tuba1a |
22142 |
Two-hybrid |
|
Mus musculus |
|
45 |
UBASH3B |
84959 |
Affinity Capture-MS |
|
Homo sapiens |
|
46 |
EFHD1 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
47 |
SMTNL2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
48 |
TRIM21 |
6737 |
Affinity Capture-MS |
|
Homo sapiens |
|
49 |
SARAF |
|
Affinity Capture-MS |
|
Homo sapiens |
|
50 |
PIGT |
51604 |
Affinity Capture-MS |
|
Homo sapiens |
|
51 |
IFI16 |
3428 |
Affinity Capture-MS |
|
Homo sapiens |
|
52 |
ARNT |
405 |
Affinity Capture-MS |
|
Homo sapiens |
|
53 |
SPRR2E |
|
Affinity Capture-MS |
|
Homo sapiens |
|
54 |
RPL36 |
25873 |
Affinity Capture-MS |
|
Homo sapiens |
|
55 |
UNC119 |
9094 |
Two-hybrid |
|
Homo sapiens |
|
56 |
ALB |
213 |
Co-fractionation |
|
Homo sapiens |
|
57 |
APTX |
|
Affinity Capture-MS |
|
Homo sapiens |
|
58 |
UPK1A |
11045 |
Affinity Capture-MS |
|
Homo sapiens |
|
59 |
DDX39B |
7919 |
Affinity Capture-MS |
|
Homo sapiens |
|
60 |
CYLD |
|
Affinity Capture-MS |
|
Homo sapiens |
|
61 |
PHF11 |
51131 |
Affinity Capture-MS |
|
Homo sapiens |
|
62 |
CNR2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
63 |
HIST1H2AI |
8329 |
Affinity Capture-MS |
|
Homo sapiens |
|
64 |
BAG3 |
9531 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Luminescence |
|
Homo sapiens |
|
65 |
CASP14 |
23581 |
Affinity Capture-MS |
|
Homo sapiens |
|
66 |
RHBDD1 |
84236 |
Affinity Capture-MS |
|
Homo sapiens |
|
67 |
BRF1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
68 |
TUBB |
203068 |
Reconstituted Complex |
|
Homo sapiens |
|
69 |
SERPINB3 |
6317 |
Affinity Capture-MS |
|
Homo sapiens |
|
70 |
PPP2R2B |
5521 |
Affinity Capture-MS |
|
Homo sapiens |
|
71 |
FANCD2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
72 |
ATP6AP2 |
10159 |
Affinity Capture-MS |
|
Homo sapiens |
|
73 |
AGPAT1 |
10554 |
Affinity Capture-MS |
|
Homo sapiens |
|
74 |
DOCK8 |
81704 |
Affinity Capture-MS |
|
Homo sapiens |
|
75 |
S100A7 |
6278 |
Affinity Capture-MS |
|
Homo sapiens |
|
76 |
NR3C1 |
2908 |
Affinity Capture-MS |
|
Homo sapiens |
|
77 |
CCNYL1 |
151195 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
78 |
SIRT7 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
79 |
EPAS1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
80 |
TBC1D22B |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
81 |
TRAF3IP1 |
26146 |
Affinity Capture-MS |
|
Homo sapiens |
|
82 |
TFAP4 |
7023 |
Affinity Capture-MS |
|
Homo sapiens |
|
83 |
SLX1B |
|
Affinity Capture-MS |
|
Homo sapiens |
|
84 |
SETD8 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
85 |
PPIA |
5478 |
Two-hybrid |
|
Homo sapiens |
|
86 |
NUAK1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
87 |
LGALS7 |
3963 |
Affinity Capture-MS |
|
Homo sapiens |
|
88 |
AURKB |
9212 |
Affinity Capture-MS |
|
Homo sapiens |
|
89 |
CDK2 |
1017 |
Affinity Capture-MS |
|
Homo sapiens |
|
90 |
LRRK1 |
79705 |
Affinity Capture-MS |
|
Homo sapiens |
|
91 |
SSUH2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
92 |
FABP5 |
2171 |
Affinity Capture-MS |
|
Homo sapiens |
|
93 |
RPA3 |
6119 |
Proximity Label-MS |
|
Homo sapiens |
|
94 |
RPL35A |
6165 |
Affinity Capture-MS |
|
Homo sapiens |
|
95 |
TCEB2 |
6923 |
Affinity Capture-MS |
|
Homo sapiens |
|
96 |
PDCD11 |
22984 |
Two-hybrid |
|
Homo sapiens |
|
97 |
RIPPLY3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
98 |
DPH6 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
99 |
APP |
351 |
Reconstituted Complex |
|
Homo sapiens |
|
100 |
ASB3 |
51130 |
Affinity Capture-MS |
|
Homo sapiens |
|
101 |
TERF2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
102 |
SIRT6 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
103 |
GRB2 |
2885 |
Affinity Capture-MS |
|
Homo sapiens |
|
104 |
CUL2 |
8453 |
Affinity Capture-MS |
|
Homo sapiens |
|
105 |
TP53 |
7157 |
Affinity Capture-MS |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
|
106 |
DOCK5 |
80005 |
Affinity Capture-MS |
|
Homo sapiens |
|
107 |
SH2D3A |
|
Affinity Capture-MS |
|
Homo sapiens |
|
108 |
MCM5 |
4174 |
Affinity Capture-MS |
|
Homo sapiens |
|
109 |
ERCC8 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
110 |
TUBGCP3 |
10426 |
Affinity Capture-MS |
|
Homo sapiens |
|
111 |
C1orf35 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
112 |
DMWD |
|
Affinity Capture-MS |
|
Homo sapiens |
|
113 |
PTDSS1 |
9791 |
Affinity Capture-MS |
|
Homo sapiens |
|
114 |
S100A9 |
6280 |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
115 |
DDX58 |
23586 |
Affinity Capture-RNA |
|
Homo sapiens |
|
116 |
NCF2 |
4688 |
Reconstituted Complex |
|
Homo sapiens |
|
117 |
S100A8 |
6279 |
Co-crystal Structure |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Co-crystal Structure |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
118 |
ESR1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
119 |
ERCC3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
120 |
TERF1 |
7013 |
Affinity Capture-MS |
|
Homo sapiens |
|
121 |
KDM1A |
23028 |
Affinity Capture-MS |
|
Homo sapiens |
|
122 |
BECN1 |
8678 |
| | | |